NDC 70710-1239-01 - acetaZOLAMIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70710-1239
- Requested NDC
- 70710-1239-01
- Package NDCs from labels
- 70710-1239-1, 70710-1239-01
- Manufacturer
- Zydus Pharmaceuticals (USA) Inc. | Zydus Lifesciences Global FZE | Zydus Lifesciences Limited
- Effective date
- 2024-03-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| acetaZOLAMIDE Tablets, USP RX Only | Zydus Pharmaceuticals (USA) Inc. | Zydus Lifesciences Global FZE | Zydus Lifesciences Limited | 2024-03-26 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70710-1239-1 | acetaZOLAMIDE | 100 in 1 BOTTLE | TABLET | 100 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70710-1239 | ACETAZOLAMIDE TABLET [ZYDUS PHARMACEUTICALS (USA) INC.] | 3 | Current NDC, 1 package rows | 20240328_85e4d8f6-1e82-4068-a768-752287d4ccf2.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acetazolamide | ACETAZOLAMIDE | Chartwell RX, LLC | f75bbf55-98ac-4f91-b6fd-17b5ac860e55 | 2024-10-10 | Warnings, Adverse reactions | 197303 197304 O3FX965V0I |
| acetazolamide | ACETAZOLAMIDE | Zydus Pharmaceuticals (USA) Inc. | bf514e99-4958-44a0-a87a-02a950f87e60 | 2024-10-08 | Warnings, Adverse reactions | O3FX965V0I |
| acetazolamide | ACETAZOLAMIDE | Zydus Lifesciences Limited | 2c1d9078-c15f-4dce-bc26-edfa5400fa9b | 2024-10-08 | Warnings, Adverse reactions | O3FX965V0I |
| Acetazolamide | ACETAZOLAMIDE | Alembic Pharmaceuticals Inc. | 43231abb-2a5d-44ab-b3e6-7564a1131ac5 | 2024-09-30 | Warnings, Adverse reactions | O3FX965V0I |
| acetaZOLAMIDE | ACETAZOLAMIDE | NuCare Pharmaceuticals,Inc. | 1b2c973f-82ef-a4f3-e063-6394a90aaae0 | 2024-08-09 | Warnings, Adverse reactions | ANDA211069 197303 O3FX965V0I |
| acetaZOLAMIDE | ACETAZOLAMIDE | Zydus Pharmaceuticals (USA) Inc. | 85e4d8f6-1e82-4068-a768-752287d4ccf2 | 2024-03-26 | Warnings, Adverse reactions | ANDA211069 70710-1239-1 70710-1238-1 70710-1238 70710-1239 70710123901 197303 197304 b8ec300c-c64c-4a65-a101-66644f64f9f7 85e4d8f6-1e82-4068-a768-752287d4ccf2 O3FX965V0I |
| Pure Cornstarch Baby | CORN STARCH | Walgreen Company | d0e9bd13-b568-4f7e-b036-8d23e71ad8bf | 2024-03-25 | Warnings | O8232NY3SJ |
| ACETAZOLAMIDE EXTENDED-RELEASE | ACETAZOLAMIDE EXTENDED-RELEASE | AvPAK | e43f991d-15b9-1e66-e053-2a95a90a9449 | 2024-01-09 | Warnings, Adverse reactions | O3FX965V0I |
| ACETAZOLAMIDE | ACETAZOLAMIDE | TRUPHARMA, LLC | 4fcd428a-7bf3-4e75-a834-1bdf1078107f | 2022-06-13 | Warnings, Adverse reactions | 197303 197304 O3FX965V0I |
| Acetazolamide | ACETAZOLAMIDE | Proficient Rx LP | 3cdde6aa-c89d-4ea4-aade-6c8b5c3ffdcc | 2019-10-01 | Warnings, Adverse reactions | 197303 O3FX965V0I |
| Acetazolamide | ACETAZOLAMIDE | Alembic Pharmaceuticals Limited | d9c1cc75-4e3d-4eaf-87c5-d5942a843818 | 2019-02-20 | Warnings, Adverse reactions | O3FX965V0I |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.